Vanguard Group Inc Helius Medical Technologies, Inc. Transaction History

Vanguard Group Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.14 - $3.48 $62,348 - $190,328	-54,692 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$3.07 - $5.55 $76,424 - $138,161	-24,894 Reduced 31.28%	54,692 $181,000
Q3 2021 Nov 12, 2021	BUY	$12.9 - $16.83 $8,875 - $11,579	688 Added 0.87%	79,586 $1.15 Million
Q2 2021 Aug 13, 2021	BUY	$13.28 - $18.45 $1.05 Million - $1.46 Million	78,898 New	78,898 $1.34 Million

Ticker HSDT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 28,197,200
Market Cap $18.3M
Description
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gai...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.